| Yale Cancer Center Retreat
Our annual retreat was a wonderful success thanks to all of the members who attended on Monday. I am especially grateful to the 18 presenters who gave excellent summaries of the exciting research currently underway in Yale Cancer Center laboratories. Each of our shared resource leaders also presented posters from their cores. Their work illustrates the huge impact these services make on successful research projects at Yale Cancer Center.
Michael Seiden, MD, PhD, President and CEO of Fox Chase Cancer Center presented his vision for Building and Stewarding Cancer Centers during the keynote address. His insights and valuable advice will be helpful to all of us as we continue to strengthen Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven in the coming years. For those of you who have asked, here is a link to the video segment he shared, "Did You Know?".
Cancer Survivors Day
Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven will celebrate Cancer Survivors Day with our patients and their families on Wednesday, May 26th at Yale's West Campus. The evening will begin with a session in the auditorium, followed by a picnic supper and entertainment. Please encourage your patients to attend with their families. I hope to see many of the clinicians and caregivers in attendance as well.
To RSVP to attend, please email Kathleen Derringer.
|
| Ellen Matloff, MS, Director of the Yale Cancer Center Genetic Counseling Program, recently participated in interviews for
NBC Nightly News and
The Today Show with health correspondent Robert Bazell to discuss the commercial availability of genetic testing kits. Walgreen's had planned to sell genetic testing kits through their stores throughout the country beginning today, but later announced they will delay their plans.
Watch the Segment on NBC Nightly News >>
Watch the Segemnt on The Today Show >>
Read all the latest news, featuring members and clinicians from Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven, online.
Read More >>
|
Nina Kadan-Lottick, MD recently received a Research Scholar Grant in Cancer Control for $600,000 from the
American Cancer Society . The grant will compare two models of cancer survivorship care. One model will be delivered by primary care physicians and the second will be provided by specialty survivorship clinics. The study will include approximately 350 patients identified through the Yale Cancer Center Rapid Case Ascertainment Shared Resource, in collaboration with the Connecticut Tumor Registry.
Cary Gross, MD and
Xiaomei Ma, PhD are co-collaborators on the project.
|
AACR's Annual Scientific Awards
The AACR is now accepting nominations for the following awards recognizing excellence in cancer research:
AACR Outstanding Investigator Award for Breast Cancer Research , funded by Susan G. Komen for the Cure® for an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer.
Nomination Deadline: May 20, 2010
Learn More >>
AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research for a scientist for his or her seminal contributions to the field of cancer prevention which have had a major impact on the field and stimulated new directions in this important area.
Nomination Deadline: July 30, 2010
Learn More >>
Breast Cancer Alliance (BCA) Young Investigator Grant
To encourage a commitment to breast cancer research, the Breast Cancer Alliance invites clinical doctors and research scientists who have been appointed to a position equivalent to Assistant Professor within three years of the appointment, and whose primary focus is breast cancer research, to apply for funding for the Young Investigator Grant.
The term of the Young Investigator Grant is two years. The grant provides salary support and project costs of $125,000 over two years. The $125,000 award includes administrative costs, which must be limited to 8% of the grant funds.
The research project must be directly related to the field of breast cancer. Areas of relevant research may include but are not limited to: diagnosis, etiology, immunology, genetics, therapies, prevention, and clinical studies.
Learn More >>
|
Cancer Prevention and Control Research Program
The Cancer Prevention and Control Research Program strives to conduct cutting-edge research to identify the causes of human cancers, and then use behavioral and other approaches to translate these findings into public health interventions to reduce cancer incidence, cancer morbidity, and mortality.
The program is organized into two themes: 1. To elucidate the role of lifestyle factors and genetics in the etiology of cancer. - Nutrition, physical activity, obesity and cancer
- Environmental factors and cancer
- Molecular/genetic factors in cancer
- Racial disparities in cancer
- Cancer biostatistics methods research
2. To evaluate behavioral interventions for cancer prevention and control. - Cancer prevention/early detection behaviors
- Secondary prevention interventions in cancer survivors
- Symptom control/quality of life in cancer patients
- Palliative and end-of-life care for cancer patients
There are currently 32 members of the Cancer Prevention and Control Research Program from seven different departments at Yale University. 23 of the members have NIH/NCI funding to support their research projects. The total cancer-related grant support for the program members in 2010 is just under $15 million.
Contact (203) 785-6392
Yong Zhu, PhDProgram Co-Director (Epidemiology/Genetics Research) (203) 785-4844
|
Recent Publications
Neurocognitive Functioning in Adult Survivors of Childhood Non-Central Nervous System Cancers.
Kadan-Lottick NS, Zeltzer LK, Liu Q, Yasui Y, Ellenberg L, Gioia G, Robison LL, Krull KR.
J Natl Cancer Inst. 2010 May 10.
Read More >>
HER-2/NEU overexpression in vulvar Paget disease: the Yale experience.
Richter CE, Hui P, Buza N, Silasi DA, Azodi M, Santin AD, Schwartz PE, Rutherford TJ.
J Clin Pathol. 2010 Apr 23.
Read More >>
PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.
Good-Jacobson KL, Szumilas CG, Chen L, Sharpe AH, Tomayko MM, Shlomchik MJ.
Nat Immunol. 2010 May 9.
Read More >>
Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines.
Chakraborty AK, Welsh A, Digiovanna MP.
Breast Cancer Res Treat. 2010 Apr;120(2):327-35.
Read More >>
The Impact of Pretreatment Prostate Volume on Severe Acute Genitourinary Toxicity in Prostate Cancer Patients Treated with Intensity-Modulated Radiation Therapy.
Aizer AA, Anderson NS, Oh SC, Yu JB, McKeon AM, Decker RH, Peschel RE.
Int J Radiat Oncol Biol Phys. 2010 May 6.
Read More >>
Human telomeres are hypersensitive to UV-induced DNA Damage and refractory to repair.
Rochette PJ, Brash DE.
PLoS Genet. 2010 Apr 29;6(4):e1000926.
Read More >>
Separating the wheat from the chaff. The search for truly informative biomarkers.
Baehring JM, Cairncross JG.
Neurology. 2010 May 5.
Read More >>
Detection of Bone Marrow Derived Lung Epithelial Cells.
Kassmer SH, Krause DS.
Exp Hematol. 2010 May 3.
Read More >>
Barriers to timely screening colonoscopy: the role of health insurance.
Mohammad A, Khan Y.
Conn Med. 2010 Apr;74(4):201-6.
Read More >>
Is there a role for mitomycin C in metastatic colorectal cancer?
Dimou A, Syrigos KN, Saif MW.
Expert Opin Investig Drugs. 2010 Apr 30.
Read More >>
Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype.
Lo SM, Stein P, Mullaly S, Bar M, Jain D, Pastores GM, Mistry PK.
Am J Hematol. 2010 May;85(5):340-5.
Read More >>
Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma.
Ferrucci LM, Cross AJ, Gunter MJ, Ahn J, Mayne ST, Ma X, Chanock SJ, Yeager M, Graubard BI, Berndt SI, Huang WY, Hayes RB, Sinha R.
World Rev Nutr Diet. 2010;101:34-45. Epub 2010 Apr 30.
Read More >>
|
| |
| Inside Yale Cancer Center
Subscribe to Yale Cancer Center Answers on iTunes
Yale Cancer Center's weekly radio program on CT Public Radio is ranked number 2 in the world for cancer programs on iTunes.
Learn More >>
Cancer Bytes
Hosted by Ellen Matloff, listen to the interviews online.
Learn More >>
Yale Cancer Center Grand Rounds
Video presentations from Yale Cancer Center members are now available online.
Learn More >>
DirectConnect Archives
Learn More >>
|
Events
May 14; 1:00 PM
Molecular Virology Research Program Conference
SHM I-116
Virus Cell-to-Cell Transmission
Walther Mothes, PhD
May 16; 6:00 PM
Yale Cancer Center Answers
WNPR 90.5
Cutaneous Malignancies
Michael Girardi, MD
Learn More >>
May 18; 12:00 PM
Yale Cancer Center Grand Rounds
55 Park Street
Radiotherapy and Cutaneous Lymphoma
Lynn Wilson, MD, MPH
Autophagy: A Common and Targetable Feature of Malignancy
Rossitza Lazova, MD
Learn More >>
May 18; 5:00 PM
Signal Transduction Research Program Conference
SHM I-116
Compartmentalized Organization: A Common and Required Feature of Stem Cell Niches?
Valentina Greco, PhD
May 19; 1:00 PM
Hematology Seminar Series
SHM I-304
Prevention of Graft v. Host Disease in Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
Stuart Seropian, MD
May 23; 6:00 PM
Yale Cancer Center Answers
WNPR 90.5
Stem Cell Transplantation
Stuart Seropian, MD and Warren Shlomchik, MD
Learn More >>
May 25; 12:00 PM
Yale Cancer Center Grand Rounds
55 Park Street
A Population Model for Smoking and Lung Cancer: Estimating the Effect of Tobacco Control in the U.S.
Theodore Holford, PhD
Neuro-Oncology at Smilow Cancer Hospital
Joachim Baehring, MD
Learn More >>
May 26; 5:30 PM
Cancer Survivors Day
Yale's West Campus
May 27; 6:00 PM
Updates and Innovations in Esophageal Cancer CME
Dolce Norwalk
|
Submissions
Please submit your recent publication and grant announcements to:
Renee Gaudette
Director, Public Affairs and Marketing
renee.gaudette@yale.edu
|
|
|
